merestinib: Clinical Trials

2 trials of merestinib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 1, Terminated 1

Follow merestinib: new trials by email Literature Review of merestinib trials Research Report on merestinib

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Merestinib In Non-Small Cell Lung Cancer And Solid Tumors
Merestinib - Carcinoma, Non-Small-Cell Lung, Solid Tumor
Phase 2TerminatedDana-Farber Cancer Institute122016-11-112024-04-11
A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer
Ramucirumab, Merestinib, Cisplatin - Biliary Tract Cancer, Metastatic Cancer
Phase 2Active not recruitingEli Lilly and Company3092016-05-192026-07-22

Conditions studied

Biliary Tract Neoplasms (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Neoplasm Metastasis (1)

Sponsors

Dana-Farber Cancer Institute (1)  ·  Eli Lilly and Company (1)

Countries

United States (2)  ·  Argentina (1)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Czechia (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Mexico (1)  ·  Russia (1)  ·  South Korea (1)  ·  Spain (1)  ·  Sweden (1)

Top investigators

Mark Awad, MD (1)

Results publications

PMID 29188469, PMID 34592180

NIH funding

2015 (1)